HCG.. Big ATH Breakout (On the way, for 500% to 1000% returns)
Fundamentally::
- Cheapest across the Hospital Industry, with 18x CFO to EBITDA
- Cancer care is in the great tailwind across developed economies, which makes HCG a good play for the long run. As India evolves into a developed country, or India positions itself as a medical treatment outsourcer.
- CEO is capable of envisioning a turnaround in the business
Technically::
- Highest strength across its industry peers
- Fresh breakout of all-time high, may go 5-10x from this level in 5-7 years.
Disclaimer:: Biased.
#Very_high_Skin_in_the_game!
- Cheapest across the Hospital Industry, with 18x CFO to EBITDA
- Cancer care is in the great tailwind across developed economies, which makes HCG a good play for the long run. As India evolves into a developed country, or India positions itself as a medical treatment outsourcer.
- CEO is capable of envisioning a turnaround in the business
Technically::
- Highest strength across its industry peers
- Fresh breakout of all-time high, may go 5-10x from this level in 5-7 years.
Disclaimer:: Biased.
#Very_high_Skin_in_the_game!
Bài đăng liên quan
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.